The Application of an Enamel Matrix Protein Derivative (Emdogain®) in Regenerative Periodontal Therapy: A Review
- 1 April 2007
- journal article
- review article
- Published by S. Karger AG in Medical Principles and Practice
- Vol. 16 (3), 167-180
- https://doi.org/10.1159/000100386
Abstract
Regenerative periodontal therapy aims at reconstitution of the lost periodontal structures such as new formation of root cementum, periodontal ligament and alveolar bone. Findings from basic research indicate that enamel matrix protein derivative (EMD) has a key role in periodontal wound healing. Histological results from animal and human studies have shown that treatment with EMD promotes periodontal regeneration. Moreover, clinical studies have indicated that treatment with EMD positively influences periodontal wound healing in humans. This review aims to present an overview of evidence-based clinical indications for regenerative therapy with EMD.Keywords
This publication has 100 references indexed in Scilit:
- Fibrin clot adhesion to dentin conditioned with protein constructs: an in vitro proof-of-principle studyJournal of Clinical Periodontology, 2005
- Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to boneLife Sciences, 2005
- Five‐year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regenerationJournal of Clinical Periodontology, 2004
- The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteinsClinical Oral Investigations, 2003
- Treatment of Intrabony Defects With Enamel Matrix Proteins or Bioabsorbable Membranes. A 4‐Year Follow‐Up Split‐Mouth StudyThe Journal of Periodontology, 2001
- A Comparative Study Utilizing Open Flap Debridement With and Without Enamel Matrix Derivative in the Treatment of Periodontal Intrabony Defects: A 12‐Month Re‐Entry StudyThe Journal of Periodontology, 2001
- Enamel Matrix Derivative in the Treatment of Human Intrabony Osseous DefectsThe Journal of Periodontology, 2000
- Comparison of treatments of infrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flapJournal of Clinical Periodontology, 2000
- Clinical safety of enamel matrix derivative (EMDOGAIN®) in the treatment of periodontal defectsJournal of Clinical Periodontology, 1997
- Towards a Cellular and Molecular Understanding of Periodontics: Cementogenesis RevisitedThe Journal of Periodontology, 1976